Could a simple exercise program strengthen bones without drugs?
NCT ID NCT05060380
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study explores whether a new type of resistance exercise is practical and safe for people with low bone mass, including those with osteopenia, osteoporosis, or sarcopenia. Over two months, one group performs progressive muscle-strengthening exercises while a control group continues normal activities. Researchers measure bone formation and breakdown markers to see if the exercise affects bone health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Progressive muscle resistive exercise
- What this could lead to
- If successful, this exercise program could offer a safe, drug-free way to help maintain or improve bone health in people with osteoporosis.
- What could go wrong
- This is a small, early feasibility study, so results may not apply broadly. The exercise may be too challenging or not effective for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Dec 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 to 70 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * independent ambulatory * diagnosed with low bone mass Exclusion Criteria: * uncontrolled hypertension * secondary osteoporosis * fragility fracture, * clinical or laboratory evidence of hepatic * renal disease, * uncontrolled disorders of the parathyroid * thyroid glands, * a history of cancer in the past 5 years, * any structured resistance training within the previous year, and * past therapy with any drug for osteoporosis, * any current therapy for osteoporosis except zoledronic acid, * inability to walk independently or * any other medical conditions which could restrict the potential participants from full participation as decided by their physician.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteopenia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can fasting plus weights strengthen aging bones?
- Pregnancy hormone hCG may hold clues to bone and gland health
- Muscle loss may predict who struggles after cancer surgery
- Can a nutritional shake keep older adults strong and sharp?
- Could a medication side effect score predict falls in older adults?
- Simple scan mistakes may skew osteoporosis diagnoses